Westergaard, what possibilities do you see in PLSIA being able to off load their $16,000,000 in inventory, most of which, I'm told, is the Centauri product which H. Schein basically returned, given their new $12.99 per procedure, 100 procedures a month (announced five days ago) lease program? Obviously, the initial cost of $40,000 wasn't working, so they came up with this lease program which includes upgrades, etc. Premiere appears to have the cash on hand to make it work.
it seems incredulous that this product wouldn't be a hit (I hold no position in the stock, although I originally bought around $12 and dumped around $11 and change for a loss, as did many, I suppose) given the FDA's backing.
forget the negative crap bw you and Pluvia for a moment, and, if you have time, respond to this inquiry. your opinions do appear to be forthright, even though this situation took a turn for the worse. thanks in advance. |
